|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D:
E.C.3.4.24.69
- bontoxilysin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Limited hydrolysis of proteins of the neuroexocytosis apparatus, synaptobrevins, SNAP25 or syntaxin. No detected action on small molecule substrates.
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
101:6888-6893
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.
|
|
B.Segelke,
M.Knapp,
S.Kadkhodayan,
R.Balhorn,
B.Rupp.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Clostridium botulinum neurotoxins (BoNTs), the most potent toxins known, disrupt
neurotransmission through proteolysis of proteins involved in neuroexocytosis.
The light chains of BoNTs are unique zinc proteases that have stringent
substrate specificity and require exceptionally long substrates. We have
determined the crystal structure of the protease domain from BoNT serotype A
(BoNT/A). The structure reveals a homodimer in a product-bound state, with loop
F242-V257 from each monomer deeply buried in its partner's catalytic site. The
loop, which acts as a substrate, is oriented in reverse of the canonical
direction for other zinc proteases. The Y249-Y250 peptide bond of the substrate
loop is hydrolyzed, leaving the Y249 product carboxylate coordinated to the
catalytic zinc. From the crystal structure of the BoNT/A protease, detailed
models of noncanonical binding and proteolysis can be derived which we propose
are also consistent with BoNT/A binding and proteolysis of natural substrate
synaptosome-associated protein of 25 kDa (SNAP-25). The proposed BoNT/A
substrate-binding mode and catalytic mechanism are markedly different from those
previously proposed for the BoNT serotype B.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Fig. 4. The S1' specificity pocket. A ball-and-stick
representation of a modeled interaction between P1' and S1' for
the homodimer with Y250 in the proposed S1' pocket. Hydrogen
bonds and ionic interactions are highlighted with yellow dashes.
This figure was generated with MIDAS (36).
|
 |
Figure 5.
Fig. 5. Catalytic mechanism. (a) A stereo view of
thermolysin residues [yellow, with side chain O atoms, red, and
side chain N atoms, blue; PDB 1TMN [PDB]
(28)] involved in catalysis is shown superimposed on the
homologous residues from BoNT/A (shown in cyan). P1 and P2 of
the cleavage product from pseudosubstrate are also shown with
the product carboxylate coordinated to the catalytic zinc.
BoNT/A LC Y365 (magenta) is shown in the conformation from
holotoxin. This figure was generated with MIDAS (36). (b) A
schematic illustration of the proposed catalytic mechanism of
250s loop hydrolysis in the BoNT/A homodimer is shown. This
figure was generated with ISIS DRAW.
|
 |
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
W.I.Lipkin
(2013).
The changing face of pathogen discovery and surveillance.
|
| |
Nat Rev Microbiol,
11,
133-141.
|
 |
|
|
|
|
 |
G.Masuyer,
M.Beard,
V.A.Cadd,
J.A.Chaddock,
and
K.R.Acharya
(2011).
Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B.
|
| |
J Struct Biol,
174,
52-57.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.H.Wang,
S.Riding,
P.Lindo,
and
B.R.Singh
(2010).
Endopeptidase activities of botulinum neurotoxin type B complex, holotoxin, and light chain.
|
| |
Appl Environ Microbiol,
76,
6658-6663.
|
 |
|
|
|
|
 |
M.Montal
(2010).
Botulinum neurotoxin: a marvel of protein design.
|
| |
Annu Rev Biochem,
79,
591-617.
|
 |
|
|
|
|
 |
Y.Fujinaga
(2010).
Interaction of botulinum toxin with the epithelial barrier.
|
| |
J Biomed Biotechnol,
2010,
974943.
|
 |
|
|
|
|
 |
A.Fischer,
Y.Nakai,
L.M.Eubanks,
C.M.Clancy,
W.H.Tepp,
S.Pellett,
T.J.Dickerson,
E.A.Johnson,
K.D.Janda,
and
M.Montal
(2009).
Bimodal modulation of the botulinum neurotoxin protein-conducting channel.
|
| |
Proc Natl Acad Sci U S A,
106,
1330-1335.
|
 |
|
|
|
|
 |
L.Maveyraud,
H.Niwa,
V.Guillet,
D.I.Svergun,
P.V.Konarev,
R.A.Palmer,
W.J.Peumans,
P.Rougé,
E.J.Van Damme,
C.D.Reynolds,
and
L.Mourey
(2009).
Structural basis for sugar recognition, including the Tn carcinoma antigen, by the lectin SNA-II from Sambucus nigra.
|
| |
Proteins,
75,
89.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Montal
(2009).
Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel.
|
| |
Toxicon,
54,
565-569.
|
 |
|
|
|
|
 |
Q.Xu,
M.E.Pichichero,
L.L.Simpson,
M.Elias,
L.A.Smith,
and
M.Zeng
(2009).
An adenoviral vector-based mucosal vaccine is effective in protection against botulism.
|
| |
Gene Ther,
16,
367-375.
|
 |
|
|
|
|
 |
V.Roxas-Duncan,
I.Enyedy,
V.A.Montgomery,
V.S.Eccard,
M.A.Carrington,
H.Lai,
N.Gul,
D.C.Yang,
and
L.A.Smith
(2009).
Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A.
|
| |
Antimicrob Agents Chemother,
53,
3478-3486.
|
 |
|
|
|
|
 |
R.Agarwal,
and
S.Swaminathan
(2008).
SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.
|
| |
J Biol Chem,
283,
25944-25951.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.T.Brunger,
M.A.Breidenbach,
R.Jin,
A.Fischer,
J.S.Santos,
and
M.Montal
(2007).
Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain.
|
| |
PLoS Pathog,
3,
1191-1194.
|
 |
|
|
|
|
 |
N.R.Silvaggi,
G.E.Boldt,
M.S.Hixon,
J.P.Kennedy,
S.Tzipori,
K.D.Janda,
and
K.N.Allen
(2007).
Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility.
|
| |
Chem Biol,
14,
533-542.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.R.Singh
(2006).
Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.
|
| |
Neurotox Res,
9,
73-92.
|
 |
|
|
|
|
 |
S.Cai,
R.Kukreja,
S.Shoesmith,
T.W.Chang,
and
B.R.Singh
(2006).
Botulinum neurotoxin light chain refolds at endosomal pH for its translocation.
|
| |
Protein J,
25,
455-462.
|
 |
|
|
|
|
 |
C.Anne,
S.Turcaud,
A.G.Blommaert,
F.Darchen,
E.A.Johnson,
and
B.P.Roques
(2005).
Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity.
|
| |
Chembiochem,
6,
1375-1380.
|
 |
|
|
|
|
 |
J.C.Burnett,
E.A.Henchal,
A.L.Schmaljohn,
and
S.Bavari
(2005).
The evolving field of biodefence: therapeutic developments and diagnostics.
|
| |
Nat Rev Drug Discov,
4,
281-297.
|
 |
|
|
|
|
 |
J.W.Arndt,
W.Yu,
F.Bi,
and
R.C.Stevens
(2005).
Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.
|
| |
Biochemistry,
44,
9574-9580.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.A.Breidenbach,
and
A.T.Brunger
(2005).
New insights into clostridial neurotoxin-SNARE interactions.
|
| |
Trends Mol Med,
11,
377-381.
|
 |
|
|
|
|
 |
M.A.Breidenbach,
and
A.T.Brunger
(2004).
Substrate recognition strategy for botulinum neurotoxin serotype A.
|
| |
Nature,
432,
925-929.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |